Changes in company's own shares

December 29, 2025 14:40 ET | Source: Alvotech Alvotech

Attached is a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding changes in company's own shares.

Attachment

Alvotech Own Shares Notification 29 Dec 2025

Attachments

Alvotech Own Shares Notification 29 Dec 2025

Alvotech Own Shares Notification 29 Dec 2025...

Recommended Reading

August 31, 2026 04:30 ET | Source: Alvotech

Alvotech Announces FDA Acceptance for Review of Biologics License Application for AVT80, Expanding Proposed Biosimilar Program for Entyvio® to Subcutaneous Presentations

REYKJAVIK, Iceland, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for...
Read More
August 31, 2026 04:30 ET | Source: Alvotech

Alvotech announces FDA acceptance for review of Biologics License Application for AVT80, expanding proposed biosimilar program for Entyvio® to subcutaneous presentations

REYKJAVIK, Iceland, August 31, 2026 - Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide,...
Read More